Etoricoxib

اتوریکوکسیب

⚠ Unverified

🦴 Musculo-Skeletal SystemSelective COX-2 inhibitor

Market / country: UK

Arcoxia (UK)

🧮 Dose calculator

Osteoarthritis · Regimen source: eMC Arcoxia · 4.2

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

  • ⛔ Active peptic ulcer or GI bleeding; bronchospasm, rhinitis, polyps, angioedema or urticaria with aspirin/NSAIDs; pregnancy and lactation; severe hepatic dysfunction; CrCl <30; under 16 y; inflammatory bowel disease; NYHA II–IV heart failure; uncontrolled BP >140/90; established ischaemic heart, peripheral arterial or cerebrovascular disease; hypersensitivity. eMC Arcoxia · 4.3

Warnings

Renal adjustment

Formulations

👥 Special populations

  • 🤰 PregnancyContraindicated

    Label: contraindicated in pregnancy. eMC Arcoxia · 4.3

    “… , experience bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions. • Pregnancy and lactation (see sections 4.6 and 5.3). • Severe hepatic dysfunction (serum albumin < 25 g/L or Child-Pugh score ≥10). • Estimated renal creatinine clearance < 30 mL/min. • Children and …”
  • 🤱 BreastfeedingContraindicated

    Label: contraindicated while breastfeeding. eMC Arcoxia · 4.3

    “… ronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions. • Pregnancy and lactation (see sections 4.6 and 5.3). • Severe hepatic dysfunction (serum albumin < 25 g/L or Child-Pugh score ≥10). • Estimated renal creatinine clearance < 30 mL/min. • Children and adolescents …”
  • 👶 ChildrenContraindicated

    Label: contraindicated in children below a stated age. eMC Arcoxia · 4.3

    “… tic dysfunction (serum albumin < 25 g/L or Child-Pugh score ≥10). • Estimated renal creatinine clearance < 30 mL/min. • Children and adolescents under 16 years of age. • Inflammatory bowel disease. • Congestive heart failure (NYHA II-IV). • Patients with hypertension whose blood pressure is persistently elevated …”
  • 👴 Older adultsNo data

    The source for this drug has no section for this group.

  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav